Colgate Announces 3rd Quarter 2013 Results
Strong Organic Sales Growth Worldwide
Net income and Diluted earnings per share in third quarter 2013 were
Net income and Diluted earnings per share in third quarter 2012 were
Excluding the above noted items in both periods, Net income in third
quarter 2013 was
Gross profit margin was 58.8% in third quarter 2013 versus 58.4% in the year ago quarter. Excluding the above noted items in both periods, Gross profit margin was 59.0% in third quarter 2013, an increase of 40 basis points versus the year ago quarter, as higher pricing and cost savings from the Company's funding-the-growth initiatives more than offset higher raw and packaging material costs which included the impact of foreign exchange.
Selling, general and administrative expenses were 35.2% of Net sales in
third quarter 2013 versus 34.6% in third quarter 2012. Excluding the
above noted items in both periods, Selling, general and administrative
expenses increased by 40 basis points to 35.0% of Net sales in third
quarter 2013, as advertising investment increased by 40 basis points and
overhead expenses remained even with the year ago period, both as a
percentage of Net sales. Worldwide advertising investment increased 6%
versus the year ago quarter to
Operating profit decreased 1% to
Net cash provided by operations year to date increased 11% to
"The strong 6.0% organic sales growth reflects positive organic growth in all operating divisions, led by the emerging markets, where organic sales grew a robust 9.5%.
"Advertising investment increased versus year ago, both absolutely and as a percent to sales, and we continue to plan for higher levels of commercial investment in the balance of the year in support of a very full pipeline of new products worldwide.
"Colgate's leading global market shares in toothpaste and manual toothbrushes remain strong at 45.0% and 33.4%, respectively, on a year-to-date basis. Pleasingly, we continue to make great progress in mouthwash as well, with our global market share in that category reaching a record high at 16.8% year to date, up 130 basis points versus prior year.
"Looking forward, we expect our growth momentum to continue in the balance of the year. We are pleased that our 2012 Restructuring Program is on track and proceeding smoothly. We also continue to be sharply focused on our aggressive worldwide funding-the-growth programs and our strategic pricing initiatives.
"Based on this, for 2013, we continue to anticipate another year of strong organic sales growth and gross margin expansion, and we continue to expect diluted earnings per share to grow 4.5% to 5.5% for the year, on a dollar basis, assuming average exchange rates in the balance of the year are equal to current spot rates."
At
The following are comments about divisional performance for third quarter 2013 versus the year ago period. See attached Geographic Sales Analysis Percentage Changes and Segment Information schedules for additional information on divisional net sales and operating profit.
North
Operating profit in
In the U.S., new product launches are contributing to volume growth
across categories. Market share gains year to date were seen in manual
toothbrushes, powered toothbrushes, mouthwash, body washes and fabric
conditioners. In toothpaste, the success of Colgate Optic White and
Colgate Optic White Dual Action toothpastes helped drive market share
for the Colgate Optic White brand to 5.5% year to date, up 0.6 share
points versus year ago. Strong sales of Colgate Total,
In manual toothbrushes, Colgate continued its brand market leadership with its market share in that category reaching a record 38.4% year to date, up 2.0 share points versus year ago. This success was driven by strong sales of Colgate 360° Optic White, Colgate 360° Total Advanced Floss Tip bristles and Colgate Extra Clean manual toothbrushes. Building on this growth momentum, Colgate Slim Soft manual toothbrush was just launched in the U.S., with robust advertising support planned to begin in the fourth quarter.
Successful products driving volume growth in the U.S. in other categories include Colgate Total Advanced Pro-Shield and Colgate Optic White mouthwashes, Softsoap brand Acai Berry & Tropical Water and Softsoap brand Coconut Island Quench body washes, Palmolive Soft Touch dish liquid and Suavitel Silky Essence fabric conditioner.
Latin
Operating profit in
Colgate's strong leadership in oral care throughout
Products in other categories contributing to volume growth include
Protex Men, Protex Vitamin E and Palmolive Naturals Olive and Aloe bar
soaps,
Operating profit in
Colgate strengthened its oral care leadership in the
Recent premium innovations contributing to volume growth in other
product categories include Colgate Max White One and
Asia (14% of Company Sales)
Operating profit in
Colgate strengthened its toothpaste leadership in
Successful new products contributing to volume growth in other categories in the region include Colgate Slim Soft Charcoal and Colgate Slim Soft Raised Tip manual toothbrushes, Colgate Optic White, Colgate Plax Fruity Fresh and Darlie mouthwashes and Palmolive Naturals Vibrant Color shampoo.
Operating profit in
Colgate continued its toothpaste leadership in
Hill's Pet Nutrition (12% of Company Sales)
Hill's Net sales increased 3.0% during third quarter 2013. Unit volume
increased 3.0%, pricing increased 3.0% and foreign exchange was negative
3.0%. Volume gains in the U.S. and
Hill's Operating profit decreased 6% in the third quarter of 2013 to
New product introductions driving volume growth in the U.S. include the recent successful launch of a new natural pet food brand, Hill's Ideal Balance, with natural ingredients perfectly balanced.
New product introductions driving volume growth globally include the launch of breakthrough weight loss nutrition, Hill's Prescription Diet Metabolic and the relaunch of Hill's Science Diet with natural ingredients and improved taste.
***
About
Market Share Information
Management uses market share information as a key indicator to monitor business health and performance. References to market share in this press release are based on a combination of consumption and market share data provided by third-party vendors, primarily Nielsen, and internal estimates. All market share references represent the percentage of the dollar value of sales of our products, relative to all product sales in the category in the countries in which the Company competes and purchases data. Market share data is subject to limitations on the availability of up-to-date information. We believe that the third-party vendors we use to provide data are reliable, but we have not verified the accuracy or completeness of the data or any assumptions underlying the data. In addition, market share information calculated by the Company may be different from market share information calculated by other companies due to differences in category definitions, the use of data from different countries, internal estimates and other factors.
Cautionary Statement on Forward-Looking Statements
This press release and the related webcast (other than historical
information) may contain forward-looking statements. Such statements may
relate, for example, to sales or volume growth, organic sales growth,
profit or profit margin growth, earnings growth, financial goals, the
impact of currency devaluations, exchange controls, price controls and
labor unrest, including in
Non-GAAP Financial Measures
The following provides information regarding the non-GAAP financial measures used in this earnings release and/or the related webcast:
This release discusses organic sales growth, which is Net sales growth
excluding the impact of foreign exchange, acquisitions and divestments.
Management believes this measure provides investors with useful
supplemental information regarding the Company's underlying sales trends
by presenting sales growth excluding the external factor of foreign
exchange as well as the impact from acquisitions and divestments. See
"Geographic Sales Analysis Percentage Changes" for the three and nine
months ended
To supplement Colgate's Condensed Consolidated Income Statements
presented in accordance with GAAP, the Company has disclosed non-GAAP
measures of operating results that exclude certain items. Worldwide
Gross profit, Gross profit margin, Selling, general and administrative
expenses, Selling, general and administrative expenses as a percentage
of Net sales, Other (income) expense, net, Operating profit, Operating
profit margin, Net income attributable to
The Company uses these financial measures internally in its budgeting process and as factors in determining compensation. While the Company believes that these financial measures are useful in evaluating the Company's business, this information should be considered as supplemental in nature and is not meant to be considered in isolation or as a substitute for the related financial information prepared in accordance with GAAP. In addition, these non-GAAP financial measures may not be the same as similar measures presented by other companies.
The Company defines free cash flow before dividends as Net cash provided
by operations less Capital expenditures. As management uses this measure
to evaluate the Company's ability to satisfy current and future
obligations, repurchase stock, pay dividends and fund future business
opportunities, the Company believes that it provides useful information
to investors. Free cash flow before dividends is not a measure of cash
available for discretionary expenditures since the Company has certain
non-discretionary obligations such as debt service that are not deducted
from the measure. Free cash flow before dividends is not a GAAP
measurement and may not be comparable to similarly titled measures
reported by other companies. See "Condensed Consolidated Statements of
Cash Flows" for the nine months ended
(See attached tables for third quarter results.)
Table 1 | |||||||||||
|
|||||||||||
Condensed Consolidated Income Statements | |||||||||||
For the Three Months Ended |
|||||||||||
(Dollars in Millions Except Per Share Amounts) (Unaudited) | |||||||||||
2013 | 2012 | ||||||||||
Net sales | $ | 4,398 | $ | 4,332 | |||||||
Cost of sales | 1,813 | 1,803 | |||||||||
Gross profit | 2,585 | 2,529 | |||||||||
Gross profit margin | 58.8 | % | 58.4 | % | |||||||
Selling, general and administrative expenses | 1,549 | 1,501 | |||||||||
Other (income) expense, net | 20 | 1 | |||||||||
Operating profit | 1,016 | 1,027 | |||||||||
Operating profit margin | 23.1 | % | 23.7 | % | |||||||
Interest (income) expense, net | - | 4 | |||||||||
Income before income taxes | 1,016 | 1,023 | |||||||||
Provision for income taxes | 317 | 326 | |||||||||
Effective tax rate | 31.2 | % | 31.9 | % | |||||||
Net income including noncontrolling interests | 699 | 697 | |||||||||
Less: Net income attributable to noncontrolling interests | 43 | 43 | |||||||||
Net income attributable to |
$ | 656 | $ | 654 | |||||||
Earnings per common share | |||||||||||
Basic | $ | 0.71 | $ | 0.69 | |||||||
Diluted | $ | 0.70 | $ | 0.68 | |||||||
Average common shares outstanding | |||||||||||
Basic | 928.1 | 949.8 | |||||||||
Diluted | 936.9 | 958.4 | |||||||||
Table 2 | |||||||||||
|
|||||||||||
Condensed Consolidated Income Statements | |||||||||||
For the Nine Months Ended |
|||||||||||
(Dollars in Millions Except Per Share Amounts) (Unaudited) | |||||||||||
2013 | 2012 | ||||||||||
Net sales | $ | 13,059 | $ | 12,799 | |||||||
Cost of sales | 5,425 | 5,372 | |||||||||
Gross profit | 7,634 | 7,427 | |||||||||
Gross profit margin | 58.5 | % | 58.0 | % | |||||||
Selling, general and administrative expenses | 4,611 | 4,443 | |||||||||
Other (income) expense, net | 359 | 37 | |||||||||
Operating profit | 2,664 | 2,947 | |||||||||
Operating profit margin | 20.4 | % | 23.0 | % | |||||||
Interest (income) expense, net | (8 | ) | 20 | ||||||||
Income before income taxes | 2,672 | 2,927 | |||||||||
Provision for income taxes | 863 | 932 | |||||||||
Effective tax rate | 32.3 | % | 31.8 | % | |||||||
Net income including noncontrolling interests | 1,809 | 1,995 | |||||||||
Less: Net income attributable to noncontrolling interests | 132 | 121 | |||||||||
Net income attributable to |
$ | 1,677 | $ | 1,874 | |||||||
Earnings per common share | |||||||||||
Basic | $ | 1.80 | $ | 1.96 | |||||||
Diluted | $ | 1.78 | $ | 1.95 | |||||||
Average common shares outstanding | |||||||||||
Basic | 932.5 | 954.8 | |||||||||
Diluted | 941.4 | 962.9 | |||||||||
Table 3 | ||||||||||||||
|
||||||||||||||
Condensed Consolidated Balance Sheets | ||||||||||||||
As of |
||||||||||||||
(Dollars in Millions) (Unaudited) | ||||||||||||||
|
|
|
||||||||||||
2013 | 2012 | 2012 | ||||||||||||
Cash and cash equivalents | $ | 721 | $ | 884 | $ | 909 | ||||||||
Receivables, net | 1,737 | 1,668 | 1,857 | |||||||||||
Inventories | 1,441 | 1,365 | 1,384 | |||||||||||
Other current assets | 701 | 639 | 611 | |||||||||||
Property, plant and equipment, net | 3,858 | 3,842 | 3,685 | |||||||||||
Other assets, including goodwill and intangibles | 4,981 | 4,996 | 4,978 | |||||||||||
Total assets | $ | 13,439 | $ | 13,394 | $ | 13,424 | ||||||||
Total debt | $ | 5,284 | $ | 5,230 | $ | 5,246 | ||||||||
Other current liabilities | 3,884 | 3,432 | 3,397 | |||||||||||
Other non-current liabilities | 2,264 | 2,342 | 2,084 | |||||||||||
Total liabilities | 11,432 | 11,004 | 10,727 | |||||||||||
|
1,784 | 2,189 | 2,507 | |||||||||||
Noncontrolling interests | 223 | 201 | 190 | |||||||||||
Total liabilities and shareholders' equity | $ | 13,439 | $ | 13,394 | $ | 13,424 | ||||||||
Supplemental Balance Sheet Information | ||||||||||||||
Debt less cash, cash equivalents and marketable securities* | $ | 4,417 | $ | 4,230 | $ | 4,256 | ||||||||
Working capital % of sales | (0.9 | )% | 0.7 | % | 2.2 | % | ||||||||
|
* |
Marketable securities of |
|
|
Table 4 | |||||||||
|
|||||||||
Condensed Consolidated Statements of Cash Flows | |||||||||
For the Nine Months Ended |
|||||||||
(Dollars in Millions) (Unaudited) | |||||||||
2013 | 2012 | ||||||||
Operating Activities | |||||||||
Net income including noncontrolling interests | $ | 1,809 | $ | 1,995 | |||||
Adjustments to reconcile net income including noncontrolling interests to net cash provided by operations: | |||||||||
Depreciation and amortization | 329 | 317 | |||||||
Restructuring and termination benefits, net of cash | 82 | (35 | ) | ||||||
Voluntary benefit plan contributions | (101 | ) | (101 | ) | |||||
Stock-based compensation expense | 105 | 98 | |||||||
|
172 | - | |||||||
Deferred income taxes | 35 | 71 | |||||||
Cash effects of changes in: | |||||||||
Receivables | (137 | ) | (166 | ) | |||||
Inventories | (107 | ) | (48 | ) | |||||
Accounts payable and other accruals | 121 | (27 | ) | ||||||
Other non-current assets and liabilities | 57 | 29 | |||||||
Net cash provided by operations | 2,365 | 2,133 | |||||||
Investing Activities | |||||||||
Capital expenditures | (419 | ) | (317 | ) | |||||
Sale of property and non-core product lines | - | 38 | |||||||
Purchases of marketable securities and investments | (408 | ) | (501 | ) | |||||
Proceeds from sale of marketable securities and investments | 195 | 120 | |||||||
Payment for acquisitions, net of cash acquired | - | (29 | ) | ||||||
Other | 4 | 65 | |||||||
Net cash used in investing activities | (628 | ) | (624 | ) | |||||
Financing Activities | |||||||||
Principal payments on debt | (5,504 | ) | (3,684 | ) | |||||
Proceeds from issuance of debt | 5,563 | 4,131 | |||||||
Dividends paid | (1,030 | ) | (951 | ) | |||||
Purchases of treasury shares | (1,115 | ) | (1,344 | ) | |||||
Proceeds from exercise of stock options and excess tax benefits | 276 | 390 | |||||||
Net cash used in financing activities | (1,810 | ) | (1,458 | ) | |||||
Effect of exchange rate changes on Cash and cash equivalents | (90 | ) | (20 | ) | |||||
Net increase (decrease) in Cash and cash equivalents | (163 | ) | 31 | ||||||
Cash and cash equivalents at beginning of period | 884 | 878 | |||||||
Cash and cash equivalents at end of period | $ | 721 | $ | 909 | |||||
Supplemental Cash Flow Information | |||||||||
Free cash flow before dividends (Net cash provided by operations less Capital expenditures) | |||||||||
Net cash provided by operations | $ | 2,365 | $ | 2,133 | |||||
Less: Capital expenditures | (419 | ) | (317 | ) | |||||
Free cash flow before dividends | $ | 1,946 | $ | 1,816 | |||||
Income taxes paid | $ | 781 | $ | 949 | |||||
Table 5 | |||||||||||||||||||
|
|||||||||||||||||||
Segment Information | |||||||||||||||||||
For the Three and Nine Months Ended |
|||||||||||||||||||
(Dollars in Millions) (Unaudited) | |||||||||||||||||||
Three Months Ended
|
Nine Months Ended
|
||||||||||||||||||
2013 | 2012 | 2013 | 2012 | ||||||||||||||||
Net sales | |||||||||||||||||||
Oral, Personal and Home Care | |||||||||||||||||||
|
$ | 774 | $ | 766 | $ | 2,300 | $ | 2,217 | |||||||||||
|
1,251 | 1,276 | 3,747 | 3,777 | |||||||||||||||
|
880 | 865 | 2,552 | 2,569 | |||||||||||||||
Asia | 627 | 583 | 1,900 | 1,717 | |||||||||||||||
|
321 | 314 | 932 | 918 | |||||||||||||||
Total Oral, Personal and Home Care | 3,853 | 3,804 | 11,431 | 11,198 | |||||||||||||||
Pet Nutrition | 545 | 528 | 1,628 | 1,601 | |||||||||||||||
Total Net sales | $ | 4,398 | $ | 4,332 | $ | 13,059 | $ | 12,799 | |||||||||||
Three Months Ended
|
Nine Months Ended
|
||||||||||||||||||
2013 | 2012 | 2013 | 2012 | ||||||||||||||||
Operating profit | |||||||||||||||||||
Oral, Personal and Home Care | |||||||||||||||||||
|
$ | 244 | $ | 213 | $ | 686 | $ | 580 | |||||||||||
|
358 | 377 | 1,022 | 1,100 | |||||||||||||||
|
216 | 198 | 605 | 560 | |||||||||||||||
Asia | 174 | 164 | 533 | 474 | |||||||||||||||
|
65 | 67 | 192 | 197 | |||||||||||||||
Total Oral, Personal and Home Care | 1,057 | 1,019 | 3,038 | 2,911 | |||||||||||||||
Pet Nutrition | 138 | 147 | 410 | 440 | |||||||||||||||
Corporate(1) | (179 | ) | (139 | ) | (784 | ) | (404 | ) | |||||||||||
Total Operating Profit | $ | 1,016 | $ | 1,027 | $ | 2,664 | $ | 2,947 | |||||||||||
Note: |
(1) Corporate operations includes costs related to stock options and restricted stock awards, research and development costs, Corporate overhead costs, restructuring and related implementation costs and gains and losses on sales of non-core product lines and assets. |
Corporate Operating profit(loss) for the three months ended
|
Corporate Operating profit(loss) for the nine months ended |
Table 6 | |||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||
Geographic Sales Analysis Percentage Changes | |||||||||||||||||||||||||||
For the Three Months Ended |
|||||||||||||||||||||||||||
(Unaudited) | |||||||||||||||||||||||||||
COMPONENTS OF SALES CHANGE | |||||||||||||||||||||||||||
Pricing | |||||||||||||||||||||||||||
Coupons | |||||||||||||||||||||||||||
Sales | 3 Months | Consumer & | |||||||||||||||||||||||||
Change | Organic | As Reported | Organic | Ex-Divested | Trade | Foreign | |||||||||||||||||||||
Region |
As Reported |
Sales Change |
Volume |
Volume |
Volume |
Incentives |
Exchange |
||||||||||||||||||||
|
1.5 | % | 6.0 | % | 5.0 | % | 5.0 | % | 5.0 | % | 1.0 | % | (4.5 | )% | |||||||||||||
|
1.5 | % | 1.0 | % | 2.0 | % | 2.5 | % | 2.5 | % | (1.5 | )% | 1.0 | % | |||||||||||||
|
(2.0 | )% | 9.5 | % | 5.5 | % | 6.0 | % | 6.0 | % | 3.5 | % | (11.0 | )% | |||||||||||||
Asia | 7.5 | % | 10.5 | % | 11.0 | % | 11.0 | % | 11.0 | % | (0.5 | )% | (3.0 | )% | |||||||||||||
|
2.0 | % | 8.5 | % | 7.5 | % | 7.5 | % | 7.5 | % | 1.0 | % | (6.5 | )% | |||||||||||||
|
1.5 | % | 7.0 | % | 6.0 | % | 6.0 | % | 6.0 | % | 1.0 | % | (5.5 | )% | |||||||||||||
|
1.0 | % | 1.5 | % | 1.5 | % | 1.5 | % | 1.5 | % | - | % | (0.5 | )% | |||||||||||||
Total CP Products | 1.5 | % | 6.0 | % | 5.0 | % | 5.0 | % | 5.0 | % | 1.0 | % | (4.5 | )% | |||||||||||||
Hill's | 3.0 | % | 6.0 | % | 3.0 | % | 3.0 | % | 3.0 | % | 3.0 | % | (3.0 | )% | |||||||||||||
Emerging Markets (1) | 2.0 | % | 9.5 | % | 7.5 | % | 7.5 | % | 7.5 | % | 2.0 | % | (7.5 | )% | |||||||||||||
Developed Markets | 1.0 | % | 2.0 | % | 1.5 | % | 2.0 | % | 2.0 | % | - | % | (0.5 | )% | |||||||||||||
Notes: |
(1) Emerging Markets include |
Table 7 | |||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||
Geographic Sales Analysis Percentage Changes | |||||||||||||||||||||||||||
For the Nine Months Ended |
|||||||||||||||||||||||||||
(Unaudited) | |||||||||||||||||||||||||||
COMPONENTS OF SALES CHANGE | |||||||||||||||||||||||||||
Pricing | |||||||||||||||||||||||||||
Coupons | |||||||||||||||||||||||||||
Sales | 9 Months | Consumer & | |||||||||||||||||||||||||
Change | Organic | As Reported | Organic | Ex-Divested | Trade | Foreign | |||||||||||||||||||||
Region |
As Reported |
Sales Change |
Volume |
Volume |
Volume |
Incentives |
Exchange |
||||||||||||||||||||
|
2.0 | % | 5.5 | % | 4.5 | % | 4.5 | % | 4.5 | % | 1.0 | % | (3.5 | )% | |||||||||||||
|
(0.5 | )% | - | % | 1.0 | % | 1.5 | % | 1.5 | % | (1.5 | )% | - | % | |||||||||||||
|
(1.0 | )% | 8.5 | % | 4.5 | % | 5.0 | % | 5.0 | % | 3.5 | % | (9.0 | )% | |||||||||||||
Asia | 10.5 | % | 11.5 | % | 11.0 | % | 11.0 | % | 11.0 | % | 0.5 | % | (1.0 | )% | |||||||||||||
|
1.5 | % | 7.0 | % | 9.0 | % | 9.0 | % | 9.0 | % | (2.0 | )% | (5.5 | )% | |||||||||||||
|
1.5 | % | 6.5 | % | 5.0 | % | 5.5 | % | 5.5 | % | 1.0 | % | (4.5 | )% | |||||||||||||
|
3.5 | % | 4.0 | % | 3.5 | % | 3.5 | % | 3.5 | % | 0.5 | % | (0.5 | )% | |||||||||||||
Total CP Products | 2.0 | % | 6.0 | % | 4.5 | % | 5.0 | % | 5.0 | % | 1.0 | % | (3.5 | )% | |||||||||||||
Hill's | 1.5 | % | 4.0 | % | 1.0 | % | 1.0 | % | 1.0 | % | 3.0 | % | (2.5 | )% | |||||||||||||
Emerging Markets (1) | 3.0 | % | 9.0 | % | 7.0 | % | 7.0 | % | 7.0 | % | 2.0 | % | (6.0 | )% | |||||||||||||
Developed Markets | 1.0 | % | 2.0 | % | 1.5 | % | 2.0 | % | 2.0 | % | - | % | (0.5 | )% | |||||||||||||
Notes: |
(1) Emerging Markets include |
|
Table 8 | ||||||||||||
|
|||||||||||||
|
|||||||||||||
Non-GAAP Reconciliations | |||||||||||||
For the Three Months Ended |
|||||||||||||
(Dollars in Millions Except Per Share Amounts) (Unaudited) | |||||||||||||
Gross Profit | 2013 | 2012 | |||||||||||
Gross profit, GAAP | $ | 2,585 | $ | 2,529 | |||||||||
2012 Restructuring Program | 8 | - | |||||||||||
Costs related to the sale of land in |
3 | 7 | |||||||||||
Business realignment and other cost-saving initiatives | - | 1 | |||||||||||
Gross profit, non-GAAP | $ | 2,596 | $ | 2,537 | |||||||||
|
|||||||||||||
Gross Profit Margin | 2013 | 2012 | Change | ||||||||||
Gross profit margin, GAAP | 58.8 | % | 58.4 | % | 40 | ||||||||
2012 Restructuring Program | 0.2 | % | - | ||||||||||
Costs related to the sale of land in |
- | 0.2 | % | ||||||||||
Business realignment and other cost-saving initiatives | - | - | |||||||||||
Gross profit margin, non-GAAP | 59.0 | % | 58.6 | % | 40 | ||||||||
Selling, General and Administrative Expenses | 2013 | 2012 | |||||||||||
Selling, general and administrative expenses, GAAP | $ | 1,549 | $ | 1,501 | |||||||||
2012 Restructuring Program | (9 | ) | - | ||||||||||
Business realignment and other cost-saving initiatives | - | (2 | ) | ||||||||||
Selling, general and administrative expenses, non-GAAP | $ | 1,540 | $ | 1,499 | |||||||||
|
|||||||||||||
Selling, General and Administrative Expenses as a Percentage of Net Sales | 2013 | 2012 | Change | ||||||||||
Selling, general and administrative expenses as a percentage of Net sales, GAAP | 35.2 | % | 34.6 | % | 60 | ||||||||
2012 Restructuring Program | (0.2 | %) | - | ||||||||||
Business realignment and other cost-saving initiatives | - | - | |||||||||||
Selling, general and administrative expenses as a percentage of Net sales, non-GAAP | 35.0 | % | 34.6 | % | 40 | ||||||||
Other (Income) Expense, Net | 2013 | 2012 | |||||||||||
Other (income) expense, net, GAAP | $ | 20 | $ | 1 | |||||||||
2012 Restructuring Program | (13 | ) | - | ||||||||||
Other (income) expense, net, non-GAAP | $ | 7 | $ | 1 | |||||||||
Operating Profit | 2013 | 2012 | % Change | ||||||||||
Operating profit, GAAP | $ | 1,016 | $ | 1,027 | (1 | %) | |||||||
2012 Restructuring Program | 30 | - | |||||||||||
Costs related to the sale of land in |
3 | 7 | |||||||||||
Business realignment and other cost-saving initiatives | - | 3 | |||||||||||
Operating profit, non-GAAP | $ | 1,049 | $ | 1,037 | 1 | % | |||||||
|
|||||||||||||
Operating Profit Margin | 2013 | 2012 | Change | ||||||||||
Operating profit margin, GAAP | 23.1 | % | 23.7 | % | (60 | ) | |||||||
2012 Restructuring Program | 0.7 | % | - | ||||||||||
Costs related to the sale of land in |
0.1 | % | 0.1 | % | |||||||||
Business realignment and other cost-saving initiatives | - | 0.1 | % | ||||||||||
Operating profit margin, non-GAAP | 23.9 | % | 23.9 | % | 0 | ||||||||
Net Income Attributable to |
2013 | 2012 | % Change | ||||||||||
Net income attributable to |
$ | 656 | $ | 654 | - | ||||||||
2012 Restructuring Program | 22 | - | |||||||||||
Costs related to the sale of land in |
2 | 5 | |||||||||||
Business realignment and other cost-saving initiatives | - | 2 | |||||||||||
Net income attributable to |
$ | 680 | $ | 661 | 3 | % | |||||||
Earnings Per Common Share, Diluted (1) (2) | 2013 | 2012 | % Change | ||||||||||
Diluted earnings per common share, GAAP | $ | 0.70 | $ | 0.68 | 3 | % | |||||||
2012 Restructuring Program | 0.02 | - | |||||||||||
Costs related to the sale of land in |
0.01 | 0.01 | |||||||||||
Business realignment and other cost-saving initiatives | - | - | |||||||||||
Diluted earnings per common share, non-GAAP | $ | 0.73 | $ | 0.69 | 6 | % | |||||||
(1) The impact of non-GAAP adjustments on the diluted earnings per share may not necessarily equal the difference between "GAAP" and "non-GAAP" as a result of rounding. |
(2) As a result of the two-for-one stock split,
effective |
Table 9 | |||||||||||||
|
|||||||||||||
Non-GAAP Reconciliations | |||||||||||||
For the Nine Months Ended |
|||||||||||||
(Dollars in Millions Except Per Share Amounts) (Unaudited) | |||||||||||||
Gross Profit | 2013 | 2012 | |||||||||||
Gross profit, GAAP | $ | 7,634 | $ | 7,427 | |||||||||
2012 Restructuring Program | 26 | - | |||||||||||
Costs related to the sale of land in |
11 | 20 | |||||||||||
Business realignment and other cost-saving initiatives | - | 5 | |||||||||||
Gross profit, non-GAAP | $ | 7,671 | $ | 7,452 | |||||||||
|
|||||||||||||
Gross Profit Margin | 2013 | 2012 | Change | ||||||||||
Gross profit margin, GAAP | 58.5 | % | 58.0 | % | 50 | ||||||||
2012 Restructuring Program | 0.2 | % | - | ||||||||||
Costs related to the sale of land in |
- | 0.2 | % | ||||||||||
Gross profit margin, non-GAAP | 58.7 | % | 58.2 | % | 50 | ||||||||
Selling, General and Administrative Expenses | 2013 | 2012 | |||||||||||
Selling, general and administrative expenses, GAAP | $ | 4,611 | $ | 4,443 | |||||||||
2012 Restructuring Program | (31 | ) | - | ||||||||||
Business realignment and other cost-saving initiatives | - | (14 | ) | ||||||||||
Selling, general and administrative expenses, non-GAAP | $ | 4,580 | $ | 4,429 | |||||||||
|
|||||||||||||
Selling, General and Administrative Expenses as a Percentage of Net Sales | 2013 | 2012 | Change | ||||||||||
Selling, general and administrative expenses as a percentage of Net sales, GAAP | 35.3 | % | 34.7 | % | 60 | ||||||||
2012 Restructuring Program | (0.2 | %) | - | ||||||||||
Business realignment and other cost-saving initiatives | - | (0.1 | %) | ||||||||||
Selling, general and administrative expenses as a percentage of Net sales, non-GAAP | 35.1 | % | 34.6 | % | 50 | ||||||||
Other (Income) Expense, Net | 2013 | 2012 | |||||||||||
Other (income) expense, net, GAAP | $ | 359 | $ | 37 | |||||||||
2012 Restructuring Program | (141 | ) | - | ||||||||||
|
(172 | ) | - | ||||||||||
Charge for a French competition law matter | (18 | ) | - | ||||||||||
Costs related to the sale of land in |
(3 | ) | - | ||||||||||
Business realignment and other cost-saving initiatives | - | (2 | ) | ||||||||||
Other (income) expense, net, non-GAAP | $ | 25 | $ | 35 | |||||||||
Operating Profit | 2013 | 2012 | % Change | ||||||||||
Operating profit, GAAP | $ | 2,664 | $ | 2,947 | (10 | %) | |||||||
2012 Restructuring Program | 198 | - | |||||||||||
|
172 | - | |||||||||||
Charge for a French competition law matter | 18 | - | |||||||||||
Costs related to the sale of land in |
14 | 20 | |||||||||||
Business realignment and other cost-saving initiatives | - | 21 | |||||||||||
Operating profit, non-GAAP | $ | 3,066 | $ | 2,988 | 3 | % | |||||||
|
|||||||||||||
Operating Profit Margin | 2013 | 2012 | Change | ||||||||||
Operating profit margin, GAAP | 20.4 | % | 23.0 | % | (260 | ) | |||||||
2012 Restructuring Program | 1.5 | % | - | ||||||||||
|
1.3 | % | - | ||||||||||
Charge for a French competition law matter | 0.2 | % | - | ||||||||||
Costs related to the sale of land in |
0.1 | % | 0.1 | % | |||||||||
Business realignment and other cost-saving initiatives | - | 0.2 | % | ||||||||||
Operating profit margin, non-GAAP | 23.5 | % | 23.3 | % | 20 | ||||||||
Net Income Attributable to |
2013 | 2012 | % Change | ||||||||||
Net income attributable to |
$ | 1,677 | $ | 1,874 | (11 | %) | |||||||
2012 Restructuring Program | 153 | - | |||||||||||
|
111 | - | |||||||||||
Charge for a French competition law matter | 18 | - | |||||||||||
Costs related to the sale of land in |
9 | 15 | |||||||||||
Business realignment and other cost-saving initiatives | - | 14 | |||||||||||
Net income attributable to |
$ | 1,968 | $ | 1,903 | 3 | % | |||||||
Earnings Per Common Share, Diluted (1) (2) | 2013 | 2012 | % Change | ||||||||||
Diluted earnings per common share, GAAP | $ | 1.78 | $ | 1.95 | (9 | %) | |||||||
2012 Restructuring Program | 0.16 | - | |||||||||||
|
0.12 | - | |||||||||||
Charge for a French competition law matter | 0.02 | - | |||||||||||
Costs related to the sale of land in |
0.01 | 0.02 | |||||||||||
Business realignment and other cost-saving initiatives | - | 0.01 | |||||||||||
Diluted earnings per common share, non-GAAP | $ | 2.09 | $ | 1.98 | 6 | % | |||||||
(1) The impact of non-GAAP adjustments on the diluted earnings per share may not necessarily equal the difference between "GAAP" and "non-GAAP" as a result of rounding. |
(2) As a result of the two-for-one stock split,
effective |
Source:
News Provided by Acquire Media